AIDS vaccine for Asia Network (AVAN): expanding the regional role in developing HIV vaccines.
The HIV/AIDS pandemic continues to spread and an AIDS vaccine is urgently needed. Regional alliances and international collaborations can foster the development and evaluation of the next generation of AIDS vaccine candidates. The importance of coordinating and harmonizing efforts across regional alliances has become abundantly clear. We recently formed the AIDS Vaccine for Asia Network (AVAN) to help facilitate the development of a regional AIDS vaccine strategy that accelerates research and development of an AIDS vaccine through government advocacy, improved coordination, and harmonization of research; develops clinical trial and manufacturing capacity; supports ethical and regulatory frameworks; and ensures community participation.
Kent
Stephen J
SJ
University of Melbourne, Parkville, Victoria, Australia.
Cooper
David A
DA
Chhi Vun
Mean
M
Shao
Yiming
Y
Zhang
Linqi
L
Ganguly
Nirmal
N
Bela
Budiman
B
Tamashiro
Hiko
H
Ditangco
Rossana
R
Rerks-Ngarm
Supachai
S
Pitisuttithum
Punnee
P
Van Kinh
Nguyen
N
Bernstein
Alan
A
Osmanov
Saladin
S
D016915:AIDS Vaccines; D001208:Asia; D035843:Biomedical Research; D002986:Clinical Trials as Topic; D014943:Global Health; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007391:International Cooperation; D058873:Pandemics
D016915:AIDS Vaccines